2019 KSHF指南:急性心衰的管理:第1部分—急性心衰的定义、流行病学和诊断

2019-01-10 韩国心衰学会 Korean Circ J. 2019 Jan;49(1):1-68.

2019年1月,韩国心衰学会(KSHF)发布了急性心衰的管理指南,指南共包括3大部分内容,分别为急性心衰的定义,流行病学和诊断,急性心衰的治疗,基于病因和共病的急性心衰的具体管理。

中文标题:

2019 KSHF指南:急性心衰的管理:第1部分—急性心衰的定义、流行病学和诊断

英文标题:

KSHF Guidelines for the Management of Acute Heart Failure: Part I. Definition, Epidemiology and Diagnosis of Acute Heart Failure

发布机构:

韩国心衰学会

发布日期:

2019-01-10

简要介绍:

2019年1月,韩国心衰学会(KSHF)发布了急性心衰的管理指南,指南共包括3大部分内容,分别为急性心衰的定义,流行病学和诊断,急性心衰的治疗,基于病因和共病的急性心衰的具体管理。 

拓展指南:心衰相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 KSHF指南:急性心衰的管理:第1部分—急性心衰的定义、流行病学和诊断)] GetToolGuiderByIdResponse(projectId=1, id=d40b61c0016919c9, title=2019 KSHF指南:急性心衰的管理:第1部分—急性心衰的定义、流行病学和诊断, enTitle=KSHF Guidelines for the Management of Acute Heart Failure: Part I. Definition, Epidemiology and Diagnosis of Acute Heart Failure, guiderFrom=Korean Circ J. 2019 Jan;49(1):1-68., authorId=null, author=, summary=2019年1月,韩国心衰学会(KSHF)发布了急性心衰的管理指南,指南共包括3大部分内容,分别为急性心衰的定义,流行病学和诊断,急性心衰的治疗,基于病因和共病的急性心衰的具体管理。 , cover=, journalId=null, articlesId=null, associationId=1757, associationName=韩国心衰学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jan 10 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年1月,韩国心衰学会(KSHF)发布了急性心衰的管理指南,指南共包括3大部分内容,分别为急性心衰的定义,流行病学和诊断,急性心衰的治疗,基于病因和共病的急性心衰的具体管理。 </div> <div><br> </div> 拓展指南:<strong>与<font color="red">心衰</font>相关指南:</strong><br><ul><li><a title="2018 CSI立场声明:心衰的管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=014121c001631124">2018 CSI立场声明:心衰的管理</a></li> <li><a title="2018年美国心脏协会《右心衰竭的评估和管理》声明解读" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=ff7c81c001629aa6">2018年美国心脏协会《右心衰竭的评估和管理》声明解读</a></li> <li><a title="2018 营养和饮食学会循证实践指南:心衰患者的管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=b6d8b1c00159324b">2018 营养和饮食学会循证实践指南:心衰患者的管理</a></li> <li><a title="2018 AHA科学声明:右心衰的评估和管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=f124c1c001580e21">2018 AHA科学声明:右心衰的评估和管理</a></li> <li><a title="2018 HFA/ESC立场声明:2型糖尿病和心衰" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=a82c61c00156e0c7">2018 HFA/ESC立场声明:2型糖尿病和心衰</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%B0">有关心衰更多指南</a></ul>, tagList=[TagDto(tagId=484, tagName=急性心衰)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7211, appHits=433, showAppHits=5, pcHits=5268, showPcHits=2498, likes=220, shares=14, comments=3, approvalStatus=1, publishedTime=Thu Jan 24 00:02:08 CST 2019, publishedTimeString=2019-01-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jan 24 00:02:08 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:08:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 KSHF指南:急性心衰的管理:第1部分—急性心衰的定义、流行病学和诊断)])
2019 KSHF指南:急性心衰的管理:第1部分—急性心衰的定义、流行病学和诊断
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1062571, encodeId=696b10625e115, content=恩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211021/fd337635fe154969b0001b0db50472a9/581f765ae23a443481e56a5ad0360399.png, createdBy=ce675643143, createdName=忳郁邑余侘傺兮, createdTime=Thu Oct 21 13:11:01 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927174, encodeId=ea2292e174a9, content=想, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87ee5451347, createdName=ms4000002054690462, createdTime=Thu Feb 25 17:56:46 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883570, encodeId=d7328835e002, content=感觉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:50:07 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2021-10-21 忳郁邑余侘傺兮

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1062571, encodeId=696b10625e115, content=恩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211021/fd337635fe154969b0001b0db50472a9/581f765ae23a443481e56a5ad0360399.png, createdBy=ce675643143, createdName=忳郁邑余侘傺兮, createdTime=Thu Oct 21 13:11:01 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927174, encodeId=ea2292e174a9, content=想, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87ee5451347, createdName=ms4000002054690462, createdTime=Thu Feb 25 17:56:46 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883570, encodeId=d7328835e002, content=感觉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:50:07 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2021-02-25 ms4000002054690462

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1062571, encodeId=696b10625e115, content=恩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211021/fd337635fe154969b0001b0db50472a9/581f765ae23a443481e56a5ad0360399.png, createdBy=ce675643143, createdName=忳郁邑余侘傺兮, createdTime=Thu Oct 21 13:11:01 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927174, encodeId=ea2292e174a9, content=想, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87ee5451347, createdName=ms4000002054690462, createdTime=Thu Feb 25 17:56:46 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883570, encodeId=d7328835e002, content=感觉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:50:07 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2020-09-08 ms1000000302953060

    感觉

    0